Unsere Forschung
Nachfolgend die Forschungsberichte des Instituts für Medizinische Mikrobiologie:
Ausgewählte aktuelle Publikationen
Weber L, Jansen M, Krüttgen A, Buhl EM, Horz HP. Tackling intrinsic antibiotic resistance in Serratia Marcescens with a combination of ampicillin/sulbactam and phage SALSA. Antibiotics (Basel). 2020 Jul 1;9(7):E371. doi: 10.3390/antibiotics9070371.
Tagliaferri TL, Guimarães NR, Pereira MPM, Vilela LFF, Horz HP*, Dos Santos SG*, Mendes TAO*. Exploring the potential of CRISPR-Cas9 under challenging conditions: facing high-copy plasmids and counteracting beta-lactam resistance in clinical strains of Enterobacteriaceae. Front Microbiol. 2020 Apr 30;11:578. doi: 10.3389/fmicb.2020.00578. *Shared last authorship
Tagliaferri TL, Jansen M, Horz HP. Fighting pathogenic bacteria on two fronts: phages and antibiotics as combined strategy. Front Cell Infect Microbiol. 2019 Feb 18;9:22. doi: 10.3389/fcimb.2019.00022.
Jansen M, Wahida A, Latz S, Krüttgen A, Häfner H, Buhl EM, Ritter K, Horz HP. Enhanced antibacterial effect of the novel T4-like bacteriophage KARL-1 in combination with antibiotics against multi-drug resistant Acinetobacter baumannii. Sci Rep. 2018 Sep 20;8(1):14140. doi: 10.1038/s41598-018-32344-y.
Wahida A, Jansen M, Ritter K, Horz HP. Bacteriophage therapy: fighting bacteria with viruses. MMW Fortschr Med. 2018 May;160(8):16-17. doi: 10.1007/s15006-018-0457-5.
Latz S, Krüttgen A, Häfner H, Buhl EM, Ritter K, Horz HP. Differential effect of newly isolated phages belonging to PB1-Like, phiKZ-Like and LUZ24-Like viruses against multi-drug resistant Pseudomonas aeruginosa under varying growth conditions. Viruses. 2017 Oct 27;9(11). pii: E315. doi: 10.3390/v9110315.
Wahida A, Ritter K, Horz HP. The Janus-face of bacteriophages across human body habitats. PLoS Pathog. 2016 Jun 23;12(6):e1005634. doi: 10.1371/journal.ppat.1005634.
